Foley's Startup Advisors answer questions that entrepreneurs need to know for their startup venture. We will be addressing questions startups regularly face – including entity formation...

Brian Lucareli, Director of Foley Private Client Services (PCS) and co-chair of the Family Offices group, sits down with Jason Kohout, partner and co-chair of the Family Offices group, ...

We are pleased to announce the release of the third and final video in our India anti-bribery compliance video series

We previously reported on the San Antonio sick leave ordinance that was to become effective August 1, 2019. City of San Antonio employers now have four extra months to comply.

It's been five years since Dodd-Frank gave whistleblowers a way to report company misdoings. What are the first things your company should do when faced with a whistleblower complaint?

The Senate passed the bill shortly after 2:00 AM EST, with the House following suit around 5:30 AM EST.

Opportunities to invest in cross-border infrastructure projects are on the rise. Foley Partner Jeff Atkin examines trends for banks and investors.

The latest episode of Energized with Foley features a dynamic conversation between Deanna Reitman and Courtney Stephens exploring the technical engine driving today’s energy industry.

The FDA's Arthritis Advisory Committee gave a thumbs up to a biosimilar copy of Johnson & Johnson's Remicade product, an inflammation blocker used in the treatment of rheumatoid arthritis, on Tuesday.

While denying certiorari usually maintains the status quo, the denial here may lead the U.S. Patent and Trademark Office (USPTO) to revisit the subject matter eligibility examples for diagnostic methods released May 4, 2016.

As you may have heard, in a published notice issued on August 19, 2022, the Department of Labor's Office of Federal Contractor Compliance (OFCCP) informed contractors that it had received...

President Trump signed an executive order yesterday that allotted additional federal resources toward the Opportunity Zone program.

Throughout previous Emerging Company Exchange posts, we've discussed the importance of intellectual property (IP) for technology companies.

The USPTO Patent Trial and Appeal Board (PTAB) issued it first institution decisions on IPR petitions filed by Kyle Bass and his Coalition for Affordable Drugs, denying institution of his challenges to two Orange-book listed patents for Ampyra.

The Trump administration is reportedly considering a proposal to charge patent holders a fee based on the value of their patents, potentially ranging from 1% to 5%.

The USPTO has issued new patent eligibility examples, including several examples relating to diagnostic methods and "nature-based" products.

The Trump administration's tariffs have reshaped global trade—but how do they impact your contracts? From force majeure to price adjustment clauses, understanding these provisions is critical for protecting your business.

The U.S. government has imposed sweeping sanctions and export controls restrictions on the Russian and Belarussian governments. With the U.S. government continuing to impose new restrictions...

California State Senator Wiener proposed SB 1047 to regulate the risks associated with AI. The bill, if enacted, would require AI developers to determine if an AI model has a "positive safety determination," ...

Foley & Lardner LLP partners Louis Lehot and Eric Chow authored the Westlaw article, "How artificial intelligence is disrupting the dealmaking process,"